• Oteseconazole Capsules approved for marketing by China NMPA

    未分类 2023-07-17

    Recently, the Category 1 innovative drug Oteseconazole Capsules of eVENUS PHARMACEUTICAL LABORATORIES INC. is approved by China NMPA. It is indicated for the treatment of severe vulvovaginal candidiasis (VVC). The approval of oteseconazole capsules for the treatment of severe VVC in China is an important milestone under Mycovia’s exclusive agreement with Hengrui to develop and commercialize oteseconazole in China, including Mainland China, Hong Kong, Macau and Taiwan, for the treatment or prevention of a range of fungal conditions. Oteseconazole, sold…

    Read More »